Letters A/H1N1 pandemic

Oseltamivir’s adverse events

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b3249 (Published 11 August 2009) Cite this as: BMJ 2009;339:b3249
  1. Mark Strong, research fellow in public health medicine1,
  2. Julia Burrows, specialist trainee in public health1,
  3. Paul Redgrave, deputy director of public health2
  1. 1ScHARR, University of Sheffield, Sheffield S1 4DA
  2. 2NHS Sheffield
  1. m.strong{at}sheffield.ac.uk

    Local community based surveillance in South Yorkshire during July 2009 indicates that only 11% (95% confidence interval 7% to 17%) of people with flu symptoms were positive for A/H1N1. Many patients who use the National Pandemic Flu Service may therefore be offered antiviral drugs unnecessarily with risk of adverse effects.1

    After …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe